Tämä sivu käännettiin automaattisesti, eikä käännösten tarkkuutta voida taata. Katso englanninkielinen versio lähdetekstiä varten.

Kortikaalisen lateralisaation vaikutus käsivarren heilahduksen selektiiviseen moottorin hallintaan itsenäisen kävelemisen aikana aivohalvauksen jälkeen.

keskiviikko 16. syyskuuta 2026 päivittänyt: University Hospital, Ghent

The upper limbs play an essential role for safe and efficient walking in healthy persons and persons post-stroke. Nevertheless, in current post-stroke gait rehabilitation (research) the upper limbs are barely targeted. To address this gap, my project aims to investigate the selective motor control of the upper limbs during walking and the contribution of the cortical activity to the arm swing in independent walkers after stroke.

To gain insight in the direct effects of stroke on the arm swing, the primary motor control of the arm swing will be evaluated by determining muscle synergies (i.e group of muscles working together as a task-specific functional unit). Additionally, the cortical activity (EEG-analysis) during walking of persons post-stroke will be compared to healthy controls and the relationship between stroke-induced changes in cortical activity and arm swing deviations will be assessed. Furthermore, I will evaluate whether improvements in cortical activity relate to improvements in primary motor control of the arm swing.

This innovative project will be the first to investigate the direct coupling between the cortex and the muscle synergies in persons post-stroke during independent walking to investigate the arm swing. These fundamental insights in the primary motor control of the arm swing and the contribution of the cortical activity will allow to develop targeted interventions aiming to improve arm swing and as such optimize post-stroke gait rehabilitation.

Research questions:

  1. How can muscle synergies explain arm swing alterations in independent walkers after stroke?
  2. How do stroke-induced changes in cortical activity relate to arm swing deviations in persons after stroke?
  3. Are changes in primary motor control of the upper limb during walking related to normalization of brain activity in independent walkers after stroke?

Tutkimuksen yleiskatsaus

Tila

Rekrytointi

Ehdot

Interventio / Hoito

Opintotyyppi

Interventio

Ilmoittautuminen (Arvioitu)

84

Vaihe

  • Ei sovellettavissa

Yhteystiedot ja paikat

Tässä osiossa on tutkimuksen suorittajien yhteystiedot ja tiedot siitä, missä tämä tutkimus suoritetaan.

Opiskeluyhteys

Tutki yhteystietojen varmuuskopiointi

Opiskelupaikat

      • Diepenbeek, Belgia, 3590
        • Rekrytointi
        • UHasselt - Faculteit Revalidatiewetenschappen
        • Ottaa yhteyttä:
        • Ottaa yhteyttä:
    • Oost-Vlaanderen
      • Ghent, Oost-Vlaanderen, Belgia
        • Rekrytointi
        • Ghent University Hospital
        • Päätutkija:
          • Arne Defour, Msc.
        • Ottaa yhteyttä:

Osallistumiskriteerit

Tutkijat etsivät ihmisiä, jotka sopivat tiettyyn kuvaukseen, jota kutsutaan kelpoisuuskriteereiksi. Joitakin esimerkkejä näistä kriteereistä ovat henkilön yleinen terveydentila tai aiemmat hoidot.

Kelpoisuusvaatimukset

Opintokelpoiset iät

18 vuotta - 70 vuotta (Aikuinen, Vanhempi Aikuinen)

Hyväksyy terveitä vapaaehtoisia

Joo

Sukupuolet, jotka voivat opiskella

Kaikki

Kuvaus

Stroke

Inclusion Criteria:

  • First-ever and cerebral stroke
  • Able to walk at least 10 minutes (FAC ≥ 3)
  • Presence of upper limb paresis (NIHSS item 5a/b > 0)

Exclusion Criteria:

  • Other neurological disorders

Healthy controls

Inclusion criteria:

  • Older than 18 years
  • Able to walk at least 10 minutes

Exlusion criteria:

  • Pregnancy

Opintosuunnitelma

Tässä osiossa on tietoja tutkimussuunnitelmasta, mukaan lukien kuinka tutkimus on suunniteltu ja mitä tutkimuksella mitataan.

Miten tutkimus on suunniteltu?

Suunnittelun yksityiskohdat

  • Ensisijainen käyttötarkoitus: Muut
  • Jako: Ei satunnaistettu
  • Inventiomalli: Rinnakkaistehtävä
  • Naamiointi: Ei mitään (avoin tarra)

Aseet ja interventiot

Osallistujaryhmä / Arm
Interventio / Hoito
Kokeellinen: Stroke

Persons with a unilateral first ever stroke

Participants have to walk without holding handrails and without bodyweight support for at least 200 gait cycles. They are asked to walk at comfortable walking speed while watching forward to a screen without virtual reality projection. Arm should be next to the body to allow arm swing if possible.

Active Comparator: Control

Age and gender matched healthy controls

Participants have to walk without holding handrails and without bodyweight support for at least 200 gait cycles. They are asked to walk at comfortable walking speed while watching forward to a screen without virtual reality projection. Arm should be next to the body to allow arm swing if possible.

Mitä tutkimuksessa mitataan?

Ensisijaiset tulostoimenpiteet

Tulosmittaus
Toimenpiteen kuvaus
Aikaikkuna
Number of muscle synergies
Aikaikkuna: Single point of assessment at inclusion

The number of muscle synergies needed to account for 90% variance in muscle activity measured by surface EMG during walking in stroke survivors compared to healthy controls. Following muscles will be examined:

  • tibialis anterior,
  • gastrocnemius lateralis
  • soleus
  • vastus medialis
  • vastus lateralis
  • rectus femoris
  • biceps femoris
  • gluteus medius
  • erector spinae
  • latissimus dorsi
  • anterior deltoid
  • posterior deltoid
  • biceps brachii
  • triceps brachii
Single point of assessment at inclusion
Number of muscle synergies
Aikaikkuna: Single point of assessment 3 months after inclusion (only for stroke survivors)

The number of muscle synergies needed to account for 90% variance in muscle activity measured by surface EMG during walking in stroke survivors after a follow-up period of three months. Following muscles will be examined:

  • tibialis anterior,
  • gastrocnemius lateralis
  • soleus
  • vastus medialis
  • vastus lateralis
  • rectus femoris
  • biceps femoris
  • gluteus medius
  • erector spinae
  • latissimus dorsi
  • anterior deltoid
  • posterior deltoid
  • biceps brachii
  • triceps brachii
Single point of assessment 3 months after inclusion (only for stroke survivors)
Weight of muscle synergies
Aikaikkuna: Single point of assessment at inclusion

The number or distribution of muscle weightings within a synergy during walking in stroke survivors compared to healthy controls.

The distribution of muscle activation averages over one gait cycle measured by surface EMG of following muscles:

  • tibialis anterior,
  • gastrocnemius lateralis
  • soleus
  • vastus medialis
  • vastus lateralis
  • rectus femoris
  • biceps femoris
  • gluteus medius
  • erector spinae
  • latissimus dorsi
  • anterior deltoid
  • posterior deltoid
  • biceps brachii
  • triceps brachii
Single point of assessment at inclusion
Weight of muscle synergies
Aikaikkuna: Single point of assessment 3 months after inclusion (only for stroke survivors)

The number or distribution of muscle weightings within a synergy during walking in stroke survivors after a follow-up period of three months.

The distribution of muscle activation averages over one gait cycle measured by surface EMG of following muscles:

  • tibialis anterior,
  • gastrocnemius lateralis
  • soleus
  • vastus medialis
  • vastus lateralis
  • rectus femoris
  • biceps femoris
  • gluteus medius
  • erector spinae
  • latissimus dorsi
  • anterior deltoid
  • posterior deltoid
  • biceps brachii
  • triceps brachii
Single point of assessment 3 months after inclusion (only for stroke survivors)
Brain symmetry index (BSI)
Aikaikkuna: Single point of assessment at inclusion

The amount of cortical lateralization during walking in stroke survivors compared to healthy controls. The score ranges from -1 to +1 with BSI = 0 reprenting perfect symmetry. Positive values represent higher power in the right hemishere compared to the left hemisphere, vice versa for negative values. For left side lesions, BSI was multiplied by -1.

Single point of assessment at inclusion
Brain symmetry index (BSI)
Aikaikkuna: Single point of assessment 3 months after inclusion (only for stroke survivors)

The amount of cortical lateralization during walking in stroke survivors after a follow-up period of three months. The score ranges from -1 to +1 with BSI = 0 reprenting perfect symmetry. Positive values represent higher power in the right hemishere compared to the left hemisphere, vice versa for negative values. For left side lesions, BSI was multiplied by -1.

Single point of assessment 3 months after inclusion (only for stroke survivors)

Toissijaiset tulostoimenpiteet

Tulosmittaus
Toimenpiteen kuvaus
Aikaikkuna
Upper limb kinematics
Aikaikkuna: Single point of assessment at inclusion

Movements of the upper limb during walking measured by 3D kinematics and expressed as angles (°)

Single point of assessment at inclusion
Upper limb kinematics
Aikaikkuna: Single point of assessment 3 months after inclusion (only for stroke survivors)

Movements of the upper limb during walking measured by 3D kinematics and expressed as angles (°)

Single point of assessment 3 months after inclusion (only for stroke survivors)
Cortico-synergy coherence
Aikaikkuna: Single point of assessment at inclusion

The amount of coherence (i.e. phase locking) between the muscle synergies and cortical activity during walking in stroke survivors compared to healthy controls. Higher values (0-1) indicate a better linear association.

Single point of assessment at inclusion
Cortico-synergy coherence
Aikaikkuna: Single point of assessment 3 months after inclusion (only for stroke survivors)

The amount of coherence (i.e phase locking) between the muscle synergies and cortical activity during walking in stroke survivors after a follow-up period of three months. Higher values (0-1) indicate a better linear association.

Single point of assessment 3 months after inclusion (only for stroke survivors)

Muut tulostoimenpiteet

Tulosmittaus
Toimenpiteen kuvaus
Aikaikkuna
National Institutes of Health Stroke Scale (NIHSS)
Aikaikkuna: Single point of assessment at inclusion (only for stroke survivors)

Quantifies the impairment caused by a stroke. The NIHSS is composed of 11 items, each of which scores a specific ability between a 0 and 4. For each item, a score of 0 typically indicates normal function in that specific ability, while a higher score is indicative of some level of impairment. The highest score is 42.

Single point of assessment at inclusion (only for stroke survivors)
National Institutes of Health Stroke Scale (NIHSS)
Aikaikkuna: Single point of assessment 3 months after inclusion (only for stroke survivors)

Quantifies the general impairment caused by a stroke after a follow-up period of three months. The NIHSS is composed of 11 items, each of which scores a specific ability between a 0 and 4. For each item, a score of 0 typically indicates normal function in that specific ability, while a higher score is indicative of some level of impairment. The highest score is 42.

Single point of assessment 3 months after inclusion (only for stroke survivors)
Fugl-Meyer assesment - Upper limbs
Aikaikkuna: Single point of assessment at inclusion (only for stroke survivors)

Assesses specifc motor impairments of the upper limbs of stroke survivors. The Fugl-Meyer Assessment scale is an ordinal scale that has 3 points for each item. A zero score is given for the item if the subject cannot do the task. A score of 1 is given when the task is performed partially and a score of 2 is given when the task is performed fully. However, reflex activity is measured using 2 points only, with a score of 0 or 2 for absence and presence of reflex respectively.

Single point of assessment at inclusion (only for stroke survivors)
Fugl-Meyer assesment - Upper limbs
Aikaikkuna: Single point of assessment 3 months after inclusion (only for stroke survivors)

Assesses specifc motor impairments of the upper limbs of stroke survivors after a follow-up period of three months. The Fugl-Meyer Assessment scale is an ordinal scale that has 3 points for each item. A zero score is given for the item if the subject cannot do the task. A score of 1 is given when the task is performed partially and a score of 2 is given when the task is performed fully. However, reflex activity is measured using 2 points only, with a score of 0 or 2 for absence and presence of reflex respectively.

Single point of assessment 3 months after inclusion (only for stroke survivors)
Tardieu scale
Aikaikkuna: Single point of assessment at inclusion (only for stroke survivors)

Quantifies spasticity by assessing the muscle's response (0-5) to different stretch velocities (V1, V2 or V3) and by determining the spasticity angle (R1 or R2).

Single point of assessment at inclusion (only for stroke survivors)
Tardieu scale
Aikaikkuna: Single point of assessment 3 months after inclusion (only for stroke survivors)

Quantifies spasticity by assessing the muscle's response (0-5) to different stretch velocities (V1, V2 or V3) and by determining the spasticity angle (R1 or R2).

Single point of assessment 3 months after inclusion (only for stroke survivors)
10 Meter Walking Test
Aikaikkuna: Single point of assessment at inclusion (only for stroke survivors)

Examins the walking capacity of a stroke survivor by measuring how long it takes to walk a distance of 10 meters (in seconds).

Single point of assessment at inclusion (only for stroke survivors)
10 Meter Walking Test
Aikaikkuna: Single point of assessment 3 months after inclusion (only for stroke survivors)

Examins the walking capacity of a stroke survivor by measuring how long it takes to walk a distance of 10 meters (in seconds).

Single point of assessment 3 months after inclusion (only for stroke survivors)
Fugl-Meyer assesment - Lower limbs
Aikaikkuna: Single point of assessment at inclusion (only for stroke survivors)

Assesses specifc motor impairments of the lower limbs of stroke survivors. The Fugl-Meyer Assessment scale is an ordinal scale that has 3 points for each item. A zero score is given for the item if the subject cannot do the task. A score of 1 is given when the task is performed partially and a score of 2 is given when the task is performed fully. However, reflex activity is measured using 2 points only, with a score of 0 or 2 for absence and presence of reflex respectively.

Single point of assessment at inclusion (only for stroke survivors)
Fugl-Meyer assesment - Lower limbs
Aikaikkuna: Single point of assessment 3 months after inclusion (only for stroke survivors)

Assesses specifc motor impairments of the lower limbs of stroke survivors after a follow-up period of three months. The Fugl-Meyer Assessment scale is an ordinal scale that has 3 points for each item. A zero score is given for the item if the subject cannot do the task. A score of 1 is given when the task is performed partially and a score of 2 is given when the task is performed fully. However, reflex activity is measured using 2 points only, with a score of 0 or 2 for absence and presence of reflex respectively.

Single point of assessment 3 months after inclusion (only for stroke survivors)

Yhteistyökumppanit ja tutkijat

Täältä löydät tähän tutkimukseen osallistuvat ihmiset ja organisaatiot.

Sponsori

Yhteistyökumppanit

Tutkijat

  • Päätutkija: Anke Van Bladel, PhD, Ghent University and Ghent University Hospital

Opintojen ennätyspäivät

Nämä päivämäärät seuraavat ClinicalTrials.gov-sivustolle lähetettyjen tutkimustietueiden ja yhteenvetojen edistymistä. National Library of Medicine (NLM) tarkistaa tutkimustiedot ja raportoidut tulokset varmistaakseen, että ne täyttävät tietyt laadunvalvontastandardit, ennen kuin ne julkaistaan ​​julkisella verkkosivustolla.

Opi tärkeimmät päivämäärät

Opiskelun aloitus (Todellinen)

Tiistai 9. heinäkuuta 2024

Ensisijainen valmistuminen (Arvioitu)

Keskiviikko 30. joulukuuta 2026

Opintojen valmistuminen (Arvioitu)

Torstai 30. syyskuuta 2027

Opintoihin ilmoittautumispäivät

Ensimmäinen lähetetty

Keskiviikko 29. toukokuuta 2024

Ensimmäinen toimitettu, joka täytti QC-kriteerit

Keskiviikko 29. toukokuuta 2024

Ensimmäinen Lähetetty (Todellinen)

Tiistai 4. kesäkuuta 2024

Tutkimustietojen päivitykset

Viimeisin päivitys julkaistu (Todellinen)

Maanantai 21. syyskuuta 2026

Viimeisin lähetetty päivitys, joka täytti QC-kriteerit

Keskiviikko 16. syyskuuta 2026

Viimeksi vahvistettu

Tiistai 1. syyskuuta 2026

Lisää tietoa

Tähän tutkimukseen liittyvät termit

Muut tutkimustunnusnumerot

  • ONZ-2024-0089
  • 11PEU24N (Muu apuraha/rahoitusnumero: FWO)

Lääke- ja laitetiedot, tutkimusasiakirjat

Tutkii yhdysvaltalaista FDA sääntelemää lääkevalmistetta

Ei

Tutkii yhdysvaltalaista FDA sääntelemää laitetuotetta

Ei

Nämä tiedot haettiin suoraan verkkosivustolta clinicaltrials.gov ilman muutoksia. Jos sinulla on pyyntöjä muuttaa, poistaa tai päivittää tutkimustietojasi, ota yhteyttä register@clinicaltrials.gov. Heti kun muutos on otettu käyttöön osoitteessa clinicaltrials.gov, se päivitetään automaattisesti myös verkkosivustollemme .